Rui-Juan Lv | Epilepsy | Best Researcher Award

Posted on 12/06/2025 by Neuroscientists

Dr. Rui-Juan Lv | Epilepsy | Best Researcher Award

Dr. Rui-Juan Lv, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China.

Dr. Lv Rui-Juan is a distinguished neurologist and researcher whose academic foundation was built at Zhengzhou University and Peking Union Medical College. Over the past decade, she has advanced through several professional roles at Beijing Tiantan Hospital, ultimately becoming Chief Physician and Associate Professor. Her research is primarily centered on epilepsy, especially temporal lobe epilepsy and autoimmune encephalitis, with a focus on advanced diagnostic techniques like FDG-PET imaging. Dr. Lv has led over 10 significant research projects and published more than 20 SCI-indexed papers, making substantial contributions to clinical neuroscience in China and beyond.

Profile

Orcid

🎓 Early Academic Pursuits

Dr. Lv Rui-Juan began her academic journey in clinical medicine at Zhengzhou University, where she earned her Bachelor’s degree between 2000 and 2005. With a solid foundation in medicine, she further pursued a Master’s degree in Neurology from the same university (2005–2007). Her thirst for deeper neurological knowledge led her to Peking Union Medical College, one of China’s top medical institutions, where she completed her Doctorate in Neurology between 2007 and 2010. These academic milestones established a strong groundwork for her future in both clinical practice and neuroscience research.

🏥 Professional Endeavors

Dr. Lv Rui-Juan’s professional path is deeply rooted in one of China’s most prestigious neurology centers—Beijing Tiantan Hospital, Capital Medical University. Since 2010, she has steadily advanced from Physician to Attending Physician, then to Deputy Chief Physician, and finally, as of December 2022, to Chief Physician. Her parallel appointment as Associate Professor since 2021 highlights her dual commitment to patient care and academic instruction. A notable period in her career includes a clinical research fellowship at the Mayo Clinic (2014–2015), which broadened her international clinical exposure and enriched her perspective in neurology.

🧠 Contributions and Research Focus

Dr. Lv’s work primarily revolves around epilepsy, with a particular focus on temporal lobe epilepsy and autoimmune encephalitis. Her expertise in the clinical and basic sciences has allowed her to lead over ten funded research projects, including prestigious grants from the National Natural Science Foundation of China and the Beijing Natural Science Foundation. Her current project investigates the application of semi-quantitative FDG-PET imaging in the early diagnosis of autoimmune encephalitis—a promising step toward improving diagnostic accuracy and therapeutic outcomes in neurology.

🏅 Accolades and Recognition

Although no individual awards or titles were explicitly listed, Dr. Lv’s rapid rise to Chief Physician and her role as Associate Professor speak volumes about her standing in the medical and academic community. Her contributions are well-acknowledged through over 20 SCI-indexed publications, many of which she authored or co-authored as the first or corresponding author. Her scholarly contributions to CNS Neuroscience & Therapeutics reinforce her recognition in the global neuroscience community.

🌐 Impact and Influence

Dr. Lv Rui-Juan’s research contributes significantly to the clinical translation of neuroscience, helping shape the way autoimmune neurological disorders are diagnosed and treated. Her collaborative approach and long-standing affiliation with Capital Medical University’s Department of Neurology position her as a key influencer in the field. Through her clinical, academic, and research roles, she has mentored peers, contributed to institutional growth, and driven forward China’s role in global neurology advancements.

📚 Legacy and Future Contributions

With a strong academic lineage, international clinical training, and significant research output, Dr. Lv Rui-Juan is well-positioned to influence the next generation of neurologists. Her commitment to combining imaging, clinical research, and patient care sets a high standard. As autoimmune and epilepsy-related disorders become more prevalent, her work on early diagnostic tools and personalized treatment strategies will likely leave a lasting legacy in neurological sciences.

🧬 Neuroscience and Innovation

At the heart of Dr. Lv’s contributions lies a commitment to neurological innovation, particularly within the domain of functional brain disorders and imaging-based diagnosis. Her ability to bridge basic science with clinical neurology through technologies like FDG-PET illustrates a forward-thinking approach. Her sustained research in autoimmune mechanisms and epilepsy pathology stands as a beacon of innovation in translational neuroscience and may pave the way for biomarker-based diagnostics in neurology.

Publication

Title: Recognition of seizure semiology and semiquantitative FDG‐PET analysis of anti‐LGI1 encephalitis
Authors: Tao‐Ran Li, Yu‐Di Zhang, Qun Wang, Xiao‐Qiu Shao, Rui‐Juan Lv
Year: 2021

Title: Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
Authors: Tao-Ran Li, Yu-Di Zhang, Qun Wang, Xiao-Qiu Shao, Zhi-Mei Li, Rui-Juan Lv
Year: 2020

Title: Clinical and genetic characteristics of type I sialidosis patients in mainland China
Authors: Rui‐Juan Lv, Tao‐Ran Li, Yu‐Di Zhang, Xiao‐Qiu Shao, Qun Wang, Li‐Ri Jin
Year: 2020

Title: Correlation between tumor necrosis factor alpha mRNA and microRNA-155 expression in rat models and patients with temporal lobe epilepsy
Authors: Tao-Ran Li, Yan-Jie Jia, Qun Wang, Xiao-Qiu Shao, Ping Zhang, Rui-Juan Lv
Year: 2018

Title: The role of the microRNA-146a/complement factor H/interleukin-1β-mediated inflammatory loop circuit in the perpetuate inflammation of chronic temporal lobe epilepsy
Authors: Tao-Ran Li, Yan-Jie Jia, Chao Ma, Wen-Ying Qiu, Qun Wang, Xiao-Qiu Shao, Rui-Juan Lv
Year: 2018

Title: Circular RNA: a new star in neurological diseases
Author: Rui-Juan Lv
Year: 2017

Title: Status epilepticus-related etiology, incidence and mortality: A meta-analysis
Author: Rui-Juan Lv
Year: 2017

Title: Significance of MDR1 gene C3435T polymorphism in predicting childhood refractory epilepsy
Author: Rui-Juan Lv
Year: 2017

Title: Temporal lobe epilepsy with amygdala enlargement: a subtype of temporal lobe epilepsy
Author: Rui-Juan Lv
Year: 2014

Title: Somatosensory reflex seizures in a patient with hypertrophic cranial pachymeningitis
Author: Rui-Juan Lv
Year: 2014

🧾 Conclusion

Dr. Lv Rui-Juan’s career reflects a well-rounded blend of clinical excellence, academic rigor, and impactful research. Her dedication to improving the early diagnosis and treatment of complex neurological disorders, such as autoimmune encephalitis and epilepsy, highlights her as a key contributor in the field of neuroscience. Her growing influence, both nationally and internationally, positions her as an ideal candidate for honors such as the Best Researcher Award, with a promising future that will likely bring further advancements in neurological science and patient care.

Katherine Mandeville | Clinical Neuroscience | Best Researcher Award

Posted on 26/05/2025 by Neuroscientists

Dr. Katherine Mandeville | Clinical Neuroscience | Best Researcher Award

Dr. Katherine Mandeville, University of California San Diego, United States.

Dr. Katherine Mandeville is a distinguished pediatric emergency physician and academician whose career reflects a commitment to excellence in both clinical care and research. With a strong academic foundation in biochemistry and medicine from the University of New Mexico, she pursued advanced clinical training at leading institutions such as the University of Colorado and Phoenix Children’s Hospital. Her academic and clinical trajectory has led her to a prominent role at the University of California, San Diego (UCSD), where she serves as an Associate Clinical Professor in the Department of Pediatrics, Division of Emergency Medicine at Rady Children’s Hospital.

Profile

Scopus
Orcid

🎓 Early Academic Pursuits

Dr. Katherine Mandeville’s journey into the medical field was rooted in a solid foundation in science and critical inquiry. She began her academic path studying biochemistry and chemical engineering at the University of New Mexico, where she also explored non-degree coursework at Albuquerque Technical Vocational Institute. Her early academic versatility revealed a strong analytical mindset and a deep interest in human health and systems. In 1999, she earned her Medical Degree from the University of New Mexico School of Medicine, setting the stage for a career centered on both patient care and research-driven excellence.

🩺 Professional Endeavors

Following her graduation from medical school, Dr. Mandeville pursued intensive clinical training at the University of Colorado Health Sciences Center, where she completed her pediatric internship, residency, and advanced to a fellowship in Pediatric Emergency Medicine at Phoenix Children’s Hospital. These formative experiences immersed her in the fast-paced, high-stakes environment of emergency pediatrics. Since joining the University of California, San Diego (UCSD), she has progressed from Associate to Assistant and now Associate Clinical Professor within the Department of Pediatrics, Division of Emergency Medicine at Rady Children’s Hospital. Her clinical role complements her academic responsibilities, fostering a dual commitment to exceptional care and education.

🔬 Contributions and Research Focus

Dr. Mandeville’s research trajectory is marked by a keen interest in bridging clinical care and evidence-based medicine. Her decision to pursue a Master of Science in Clinical Research at the University of New Mexico’s Health Sciences Center demonstrates a deliberate move toward translational science and healthcare innovation. Her work integrates real-world clinical challenges in pediatric emergency departments with scientific inquiry, focusing on improving outcomes for vulnerable pediatric populations. While her biography does not specify individual research projects or publications, her advanced training and consistent academic appointments suggest active involvement in research development, collaborative studies, or clinical protocols aimed at advancing pediatric emergency medicine.

🏆 Accolades and Recognition

Dr. Mandeville’s credentials reflect longstanding recognition in the field of pediatrics. She is certified by the American Board of Pediatrics in both General Pediatrics and Pediatric Emergency Medicine—a rare and prestigious combination. Her sustained licensure in California and prior credentials in Nevada highlight her clinical credibility, while her affiliation with institutions such as UCSD and Rady Children’s Hospital place her in nationally ranked centers of pediatric care. The progression of her academic titles further underscores institutional trust in her leadership, mentorship, and research capabilities.

🌍 Impact and Influence

Throughout her career, Dr. Mandeville has consistently served at the intersection of medicine, mentorship, and systemic impact. At Rady Children’s Hospital—a major referral center in Southern California—she has influenced both the quality of emergency pediatric care and the professional development of young physicians. Her expertise and clinical judgment are undoubtedly shaping the training experiences of future pediatricians, residents, and fellows. Moreover, her presence in a teaching hospital and research-driven university ensures that her influence extends beyond clinical settings into broader academic and public health circles.

🔗 Legacy and Future Contributions

Dr. Mandeville is well-positioned to leave a lasting legacy in pediatric emergency care and clinical education. With her strong academic background, research training, and high-level clinical experience, she represents the next generation of clinician-researchers dedicated to evidence-based improvements in pediatric health. Her ongoing work at UCSD is likely to contribute to innovations in emergency care delivery, interdisciplinary teaching, and policy development in children’s health services. As medical systems increasingly prioritize translational research and quality improvement, her dual role as educator and researcher will only grow more pivotal.

🧪 Commitment to Research-Driven Medicine

What sets Dr. Mandeville apart is her integration of research training into her clinical identity. The MSCR program she completed reflects a structured and methodical approach to data analysis, study design, and outcomes research—skills that are vital in transforming bedside observations into peer-reviewed evidence. While not all research is visible in public citations, her long-term affiliation with academic medical centers and role in an evidence-based specialty suggests a strong alignment with research objectives. Her career embodies the principle that the best medical care is informed by rigorous scientific investigation, continuous learning, and collaborative innovation.

Publication

Title: Effects of Timing to Diagnosis and Appendectomy in Pediatric Appendicitis
Author(s): Mandeville K, Monuteaux M, Pottker T, Bulloch B
Year: 2015

Title: The Frequency of Postreduction Interventions After Successful Enema Reduction of Intussusception
Author(s): Lessenich EM, Kimia AA, Mandeville K, Li J, Landschaft A, Tsai A, Bachur R
Year: 2015

Title: Intussusception: Clinical Presentations and Imaging Characteristics
Author(s): Mandeville K, Chien M, Willyerd FA, Mandell G, Hostetler MA, Bulloch B
Year: 2012

Title: Management of the Child After Enema-Reduced Intussusception: Hospital or Home?
Author(s): Chien M, Willyerd FA, Mandeville K, Hostetler MA, Bulloch B
Year: 2012

Title: Using Appendicitis Scores in the Pediatric ED
Author(s): Mandeville K, Pottker T, Bulloch B, Liu J
Year: 2010

Title: Brain Oxygen Utilization Is Unchanged by Hypoglycemia in Normal Humans: Lactate, Alanine, and Leucine Uptake Are Not Sufficient to Offset Energy Deficit
Author(s): Lubow JM, Piñón IG, Avogaro A, Cobelli C, Treeson DM, Mandeville KA, Toffolo G, Boyle PJ
Year: 2005

Title: Presentation, Evaluation, and Outcomes of Infants Under Three Months With Skull Fractures
Author(s): Mandeville K
Year: Not specified (date not provided in source)

🏁 Conclusion

Dr. Katherine Mandeville exemplifies the role of a clinician-researcher in modern medicine. Her robust educational background, commitment to pediatric emergency care, and pursuit of research-driven solutions have positioned her as a valuable leader in her field. Her influence spans clinical innovation, academic mentorship, and systemic healthcare improvements, making her a key contributor to both pediatric patient outcomes and medical education. As she continues her work at UCSD and Rady Children’s Hospital, her legacy is poised to grow through impactful research, mentorship, and advocacy for best practices in pediatric emergency medicine.

stefano | Clinical Neuroscience | Innovative Research Award

Posted on 12/05/202512/05/2025 by Neuroscientists

Dr. Stefano | Clinical Neuroscience | Innovative Research Award

Dr. Stefano, Ospedale Santa Chiara Trento, Italy.

Dr. Stefano Branzoli is a highly accomplished cardiac surgeon with decades of experience spanning Italy, Belgium, and the United States. After completing his medical studies at the University of Pavia, he advanced through elite international training, including a fellowship at the Mayo Clinic. His career has focused on surgical innovation in cardiac electrophysiology, with particular emphasis on thoracoscopic ablation for atrial fibrillation, stroke prevention, and ventricular arrhythmias. Through his roles at Santa Chiara Hospital and Universitair Ziekenhuis Brussel, he has contributed extensively to both clinical practice and academic research.

Profile

Orcid

🧬 Early Academic Pursuits

Dr. Stefano Branzoli began his journey into medicine at the prestigious University of Pavia, where he earned his degree in Medicine and Surgery between 1992 and 1998. Driven by a deep curiosity for cardiovascular science, he embarked on rigorous postgraduate training, marking the start of an extraordinary career in cardiac surgery. His academic excellence soon opened international doors, including a coveted fellowship at the Mayo Clinic in Rochester, Minnesota.

🏥 Professional Endeavors

From 1999 to 2004, Dr. Branzoli honed his clinical expertise as a resident in cardiac surgery at the University of Pavia. He became board-certified after completing the USMLE in 2000, equipping him with transatlantic qualifications. Since 2005, he has served in the Cardiac Surgery Unit at Santa Chiara Hospital in Trento, Italy, while also expanding his reach as a specialist at the Universitair Ziekenhuis Brussel in Belgium since 2019. These dual roles reflect his commitment to advancing surgical standards across borders.Contributions to Cardiac ElectrophysiologyThroughout his career, Dr. Branzoli has been instrumental in the development and refinement of procedures targeting arrhythmias. His clinical and research contributions in thoracoscopic ablation for atrial fibrillation, stroke prevention, and epicardial ablation for ventricular arrhythmias have positioned him as a leading voice in electrophysiological cardiac surgery. He has been particularly focused on minimally invasive techniques that reduce patient recovery time while enhancing procedural efficacy.

🔬 Research Focus and Innovation

Dr. Branzoli’s research portfolio reflects his dedication to solving complex cardiovascular challenges. He has led and contributed to significant projects centered on atrial fibrillation, stroke prevention strategies, and novel ablative techniques. His work bridges the gap between traditional surgical approaches and cutting-edge electrophysiological interventions, helping shape the future of cardiac care through both clinical practice and investigative science.

🏅 Accolades and Recognition

Though modest in demeanor, Dr. Branzoli’s accomplishments have earned him respect in academic and clinical circles alike. His training at the Mayo Clinic—a global epicenter for cardiac research—along with his dual appointments in Italy and Belgium, speak volumes of his international reputation. His involvement in advanced cardiac rhythm management has earned recognition from peers and institutions aiming to elevate surgical excellence.

🌍 Impact and Influence

Beyond the operating theater, Dr. Branzoli’s influence is reflected in the widespread adoption of thoracoscopic ablation techniques and his mentorship of upcoming cardiac surgeons in Europe. By integrating cross-border expertise, he has played a vital role in aligning surgical standards and promoting collaborative research between institutions in Italy, Belgium, and beyond.

🔮 Legacy and Future Contributions

As medicine evolves toward personalized, minimally invasive therapies, Dr. Branzoli stands at the forefront of surgical innovation. His work continues to inspire new pathways in arrhythmia management and stroke prevention. With a career spanning continents and a mind open to continual learning, his legacy is defined not only by lives saved but also by knowledge passed on to future generations of cardiovascular specialists.

Publication

Title: Patients with Gastrointestinal Bleeding and Atrial Fibrillation: Potential Ideal Target for Epicardial Appendage Occlusion
Authors: Stefano Branzoli, Massimiliano Marini, Domenico Catanzariti, Cecilia Pravadelli, Luigi Pannone, Giovanni D’Onghia, Mauro Fantinel, Fabrizio Guarracini, Gaia Franceschini, Mirco Zadro et al.
Year: 2025

Title: Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective
Authors: Stefano Branzoli, Fabrizio Guarracini, Massimiliano Marini, Giovanni D’Onghia, Domenico Catanzariti, Elettra Merola, Luciano Annicchiarico, Giulia Casagranda, Chiara Stegagno, Mauro Fantinel et al.
Year: 2022

✅ Conclusion

Dr. Branzoli’s enduring commitment to advancing cardiac surgery has had a meaningful impact on patient care, research, and education. With a legacy rooted in innovation, cross-cultural collaboration, and a passion for arrhythmia management, he continues to influence the evolving field of cardiovascular medicine. His work serves as a bridge between traditional surgical methods and modern electrophysiological therapies—ensuring that the future of heart care is not only safer and more effective but also profoundly human-centered.

Janine Hicks | Emerging Areas in Neuroscience |

Posted on 06/05/2025 by Neuroscientists

Dr. Janine Hicks | Emerging Areas in Neuroscience | Best Researcher Award

Dr. Janine Hicks, University of KwaZulu-Natal, South Africa.

Janine Louise Hicks is a distinguished South African academic and human rights advocate with over 30 years of experience in law, gender justice, and community development. Her academic journey includes degrees from the University of Cape Town, UNISA, Sussex University, and the University of KwaZulu-Natal, culminating in a Ph.D. focused on participatory development and social change. Currently a Senior Lecturer in Law at UKZN, she has played pivotal roles in both academia and civil society, offering expert legal and policy insights on gender equality, legislative reform, and international development frameworks. Janine has represented South Africa in global gender forums and contributed extensively to the analysis of state compliance with international gender conventions. Her leadership on non-profit boards and her participation in key policy spaces highlight her enduring commitment to transforming legal and social systems for marginalized communities.

Profile

Google Scholar

🎓 Early Academic Pursuits

Janine Louise Hicks embarked on her academic journey with a strong foundation in the humanities, earning a Bachelor of Arts degree from the University of Cape Town between 1987 and 1989. Driven by a passion for justice and human rights, she pursued a Bachelor of Laws (LLB) from UNISA, completing it in 1994. Her interest in development, social justice, and participatory governance led her to the University of Natal, where she further enriched her legal education from 1995 to 1996. Committed to understanding grassroots development, Janine advanced her studies internationally, obtaining an MA in Participation, Development and Social Change from the Institute of Development Studies at Sussex University in the UK in 2005. Her academic journey culminated in a Ph.D. from the University of KwaZulu-Natal (2019–2021), reflecting her commitment to scholarly inquiry in gender and development.

👩‍🏫 Professional Endeavors

Janine Hicks’s professional path spans more than three decades in the fields of social justice, community development, and human rights. Currently serving as a Senior Lecturer in the School of Law at the University of KwaZulu-Natal, she has spent the last eight years mentoring future leaders in law and justice. Her work has been rooted in providing legal insights and academic leadership while bridging theory and practice. Janine’s career also encompasses substantial experience with non-profit and civil society organizations, where she has held leadership roles on several boards, ensuring that gender and participatory approaches remain central to institutional mandates and development strategies.

📚 Contributions and Research Focus

Janine’s research has focused intensively on the intersections of gender, law, and development, particularly in assessing and enhancing state mechanisms for gender equality. Her work delves into policy and legislative analysis, gender mainstreaming in public planning, and aligning national frameworks with international gender justice protocols. She has contributed significantly to the evaluation of state compliance with global and regional gender conventions, provided critical reports to Parliament, and engaged in global forums such as the United Nations Commission on the Status of Women. Through her research and advocacy, she has offered comprehensive recommendations to bridge gender gaps in policy and practice, shaping institutional transformation in South Africa and beyond.

🏅 Accolades and Recognition

While Janine does not list formal professional memberships, her influence is evident in the high-level positions she has held within civil society. She has served as Chairperson of the Board of Trustees at The Valley Trust, Chairperson of the Board of Directors at the Community Law and Rural Development Centre, and Chairperson of Agenda Feminist Media—testaments to the trust placed in her leadership and strategic vision. Her commitment to justice and equality has made her a respected voice in policy circles and advocacy spaces, especially in the fields of gender rights and participatory development.

🌍 Impact and Influence

Janine’s work has created a lasting impact on the formulation and reform of gender-sensitive legislation, as well as on the capacity of institutions to respond to the needs of marginalized communities. Her gender analysis has shaped development programs, contributed to institutional frameworks, and ensured that women’s voices are amplified in governance processes. Her advisory role at the Denis Hurley Centre reflects her continued influence on public interest law and social equity programming. She has also played a vital role in international dialogue, influencing negotiation and resolution processes at global platforms.

🔍 Legacy and Future Contributions

As an educator, Janine is cultivating a new generation of legal scholars and social justice advocates. Her legacy lies not only in the research she has produced and the reforms she has helped shape, but also in her role as a mentor and thought leader in feminist legal education. Looking ahead, Janine is poised to continue her impactful research and policy engagement, furthering academic discourse around gender justice and participatory governance in both South African and international contexts.

💡 Vision for Inclusive Development

At the heart of Janine Hicks’s work is a vision for an inclusive and equitable society, driven by participation, transparency, and gender justice. Her multidisciplinary expertise—spanning law, development, and social change—positions her as a champion for rights-based development. Whether through academic research, civil society leadership, or international advocacy, Janine continues to be a vital force in ensuring that the principles of justice and equality are upheld in law and lived in practice.

Publication

Title: Community development and engagement with local governance in South Africa
Authors: I Buccus, D Hemson, J Hicks, L Piper
Year: 2008

Title: Public participation and local governance
Authors: I Buccus, D Hemson, J Hicks, L Piper
Year: 2007

Title: Crafting new democratic spaces: participatory policy-making in KwaZulu-Natal, South Africa
Authors: J Hicks, I Buccus
Year: 2008

Title: Strengthening women’s participation in local governance: Lessons and strategies
Author: J Hicks
Year: 2011

Title: Assessing the effectiveness of community based involvement
Author: J Hicks
Year: 2006

Title: Democratisation with inclusion: revisiting the role of ward committees
Authors: I Buccus, J Hicks
Year: 2008

Title: South Africa: Expanding into
Authors: D Budlender, J Hicks, L Vetten
Year: 2002

Title: Bringing women into local governance: a review of enabling mechanisms in South Africa
Author: J Hicks
Year: 2011

Title: Civil society and participatory policy making in South Africa: Gaps and opportunities
Authors: I Buccus, J Hicks
Year: 2011

Title: ‘The wages are low but they are better than nothing’: The Dilemma of Decent Work and Job Creation in South Africa
Authors: M Williams, E Webster, K von Holdt, N Southern, R Southall, K Skinner, …
Year: 2011

✅ Conclusion

Janine Hicks’s career reflects a powerful blend of scholarship, advocacy, and leadership. Her deep-rooted expertise in gender and development, combined with her legal acumen, has positioned her as a vital contributor to South Africa’s democratic and feminist legal discourse. Through education, research, and civic engagement, she continues to shape more inclusive policies and empower future changemakers. Her legacy is one of courage, compassion, and commitment to social justice—an inspiring model for interdisciplinary and impactful work in human rights and development.

Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Posted on 02/05/2025 by Neuroscientists

Prof. Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng, Wake Forest University School of Medicine, United States.

Dr. Che Ping Cheng, M.D., Ph.D., FAHA, is a distinguished cardiovascular physiologist and internal medicine specialist whose career has been dedicated to advancing the understanding of heart function and failure. From earning his medical degree in China to completing a Ph.D. in Physiology at Wayne State University, and later conducting pivotal postdoctoral research at Wake Forest School of Medicine, Dr. Cheng has consistently pursued excellence in science and education. His research on ventricular mechanics, volume loading, and heart failure has significantly influenced both experimental cardiology and clinical practice. Recognized as a Fellow of the American Heart Association, he is also a dedicated mentor, shaping the next generation of cardiovascular researchers through his academic leadership.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Che Ping Cheng’s journey into medicine and science began in Nanjing, China, where he earned his M.D. degree from Nanjing Railway Medical University in 1977. His early academic path reflected a deep interest in understanding the intricacies of human health, particularly in cardiovascular physiology. Driven by a desire to expand his knowledge and research capabilities, Dr. Cheng pursued his Ph.D. in Physiology at Wayne State University School of Medicine in Detroit, Michigan, completing his degree in 1986. Under the mentorship of Dr. Robert S. Shepard, his doctoral work focused on exploring the mechanisms of cardiovascular response to volume loading in a canine model with tricuspid valvulectomy, setting a strong foundation for his lifelong focus on heart function and disease mechanisms.

🩺 Professional Endeavors

Following his academic training, Dr. Cheng embarked on postdoctoral studies at the Bowman Gray School of Medicine (now part of Wake Forest School of Medicine), where he continued to cultivate his expertise in internal medicine and cardiovascular physiology. Between 1986 and 1988, he served as a Postdoctoral Fellow under the guidance of Dr. William C. Little. His research during this period focused on ventricular dynamics and the physiological factors affecting active ventricular filling, which would later inform his broader work on heart failure and cardiac function. Dr. Cheng has since remained at Wake Forest School of Medicine, where he is currently a distinguished member of the Section on Cardiovascular Medicine.

🧪 Contributions and Research Focus

Dr. Cheng’s career has been characterized by a deep commitment to advancing the understanding of cardiac hemodynamics, ventricular interaction, and heart failure mechanisms. His research has explored how ventricular function responds under altered physiological states, and how these responses inform disease progression and treatment strategies. His early animal model studies have provided critical insights into the interplay between structural and functional changes in the heart, especially in the context of diastolic dysfunction and volume overload conditions. Dr. Cheng has also made significant strides in translating these findings to clinical contexts, influencing how cardiologists approach diagnosis and therapy.

🏅 Accolades and Recognition

Throughout his career, Dr. Cheng has received considerable recognition for his scholarly contributions. He is a Fellow of the American Heart Association (FAHA), an honor that reflects his standing in the field of cardiovascular research and his commitment to scientific excellence. His work has earned the respect of colleagues and institutions alike, leading to numerous invitations to contribute to collaborative projects, serve on peer-review panels, and mentor future generations of cardiovascular researchers.

🌍 Impact and Influence

Dr. Cheng’s work has had a lasting impact on both experimental and clinical cardiology. By elucidating the mechanistic basis of ventricular dysfunction, he has helped shift paradigms in heart failure management, particularly in the areas of ventricular interdependence and preload responsiveness. His research findings are frequently cited in textbooks and high-impact journals, and they continue to inform guidelines for cardiac care and interventions. Through his work at Wake Forest and beyond, Dr. Cheng has played a pivotal role in bridging laboratory discoveries with bedside applications.

👨‍🏫 Legacy and Mentorship

As a respected mentor and educator, Dr. Cheng has dedicated a significant portion of his career to training medical students, residents, and postdoctoral fellows. His mentorship has influenced numerous emerging scholars in cardiovascular medicine, many of whom have gone on to successful academic and clinical careers. His guidance combines a rigorous scientific approach with a deep sense of responsibility to patient care and scientific integrity, shaping a legacy that extends well beyond his own research output.

🔬 Future Contributions and Vision

Looking ahead, Dr. Cheng remains committed to the advancement of cardiovascular research, with a continued focus on uncovering the cellular and mechanical determinants of heart disease. His vision includes fostering collaborative projects that integrate biomedical engineering, imaging, and computational modeling to further understand cardiac performance. With decades of experience and a forward-thinking approach, Dr. Cheng’s future contributions are poised to leave a lasting mark on the field of translational cardiovascular medicine.

Publication

Title: Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
Authors: Sun, Xiaoqiang; Cao, Jing; Chen, Zhe; Ferrario, Carlos M.; Cheng, Cheping
Year: 2023
Journal: Heliyon

Title: Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
Authors: Mikhailov, Alexei V.; Liu, Yixi; Cheng, Hengjie; Lin, Jen Jar; Cheng, Cheping
Year: 2022
Journal: Heliyon

Title: Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms
Authors: Zhang, Xiaowei; Li, Tiankai; Cheng, Hengjie; Groban, Leanne; Cheng, Cheping
Year: 2021
Journal: Life Sciences

Title: Chronic Ca2+/calmodulin-dependent protein Kinase II inhibition rescues advanced heart failure
Authors: Liu, Yixi; Shao, Qun; Cheng, Hengjie; Zhao, David Xiao Ming; Cheng, Cheping
Year: 2021
Journal: Journal of Pharmacology and Experimental Therapeutics

Title: The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
Authors: Ferrario, Carlos M.; Groban, Leanne; Wang, Hao; Sun, Xuming; Ahmad, Sarfaraz
Year: 2021
Journal: Molecular and Cellular Endocrinology

Title: Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
Authors: Li, Tiankai; Zhang, Zhi; Zhang, Xiaowei; Ferrario, Carlos M.; Cheng, Cheping
Year: 2020
Journal: International Journal of Cardiology

Title: Female Heart Health: Is GPER the Missing Link?
Authors: Groban, Leanne; Tran, Q. K.; Ferrario, Carlos M.; Wang, Hao; Lindsey, Sarah H.
Year: (Not specified, but likely 2020 or 2021)
Journal: (Not specified)

🏁 Conclusion

Dr. Cheng’s legacy is one of intellectual rigor, clinical relevance, and mentorship. His work has not only deepened the scientific understanding of cardiac physiology but has also shaped modern approaches to diagnosing and managing heart failure. With a career spanning continents and disciplines, Dr. Cheng continues to be a guiding force in cardiovascular medicine, and his future contributions are anticipated to further advance the frontiers of heart research and patient care.

Mustafa Nazıroğlu | Cellular Neuroscience | Neuroscience Research Excellence Award

Posted on 29/04/2025 by Neuroscientists

Prof. Mustafa Nazıroğlu | Cellular Neuroscience | Neuroscience Research Excellence Award

Prof. Mustafa Nazıroğlu, Suleyman Demirel University, Turkey.

Professor Mustafa Nazıroğlu is a distinguished scholar with dual doctorates in Physiology and Neuroscience. Beginning his academic journey at Fırat University and advancing to leadership roles at Süleyman Demirel University, he has become a global authority in the fields of oxidative stress, calcium signaling, and TRP ion channels. His research portfolio includes over 270 peer-reviewed articles and thousands of citations, showcasing a profound impact on cellular neuroscience. Beyond research, he has led major international congresses, served on editorial boards of top journals, and has been honored with numerous awards and fellowships in Europe, Asia, and North America.

Profile

Orcid

🎓 Early Academic Pursuits

Professor Mustafa Nazıroğlu embarked on his academic journey with a degree from the Faculty of Veterinary Medicine at Fırat University in 1991. Driven by a profound curiosity for physiological mechanisms, he pursued a Ph.D. in Physiology at the same institution, which he completed between 1992 and 1996. His academic ambitions later led him to earn a second Ph.D. in Neuroscience from Süleyman Demirel University (SDU) in 2018, reflecting his commitment to interdisciplinary scholarship and continuous learning.

🧠 Professional Endeavors in Neuroscience and Biophysics

Currently, Professor Nazıroğlu holds the position of Head of the Department of Biophysics and Neuroscience at SDU Medical Faculty. His professional path has been shaped by a deep dedication to academic leadership, having served in several key roles including department head, director of the Neuroscience Research Centre (NOROBAM), and chair of numerous international scientific congresses. Notably, he has successfully organized the biennial International World Congress of Oxidative Stress, Calcium Signalling and TRP Channels from 2006 to 2020, as well as the International Brain Research School series from 2015 to 2024. His influence has also reached global platforms, including service on the organizing committee for the TEMA-14 Congress in Hubei, China, in 2011.

🔬 Contributions and Research Focus

A prolific researcher, Professor Nazıroğlu has significantly advanced our understanding of oxidative stress, calcium signaling, apoptosis, and ion channel (TRP) physiology. His scientific output includes 274 international research articles, 19 review papers, and six book chapters, collectively amassing over 11,500 citations and earning him a Scopus h-index of 59. He has also contributed as an editorial and reviewing member for leading journals such as Biological Trace Element Research, Scientific Reports (Nature Publishing), Frontiers in Physiology, and Current Neuropharmacology, among others. His research has bridged cellular neuroscience with therapeutic strategies, making him a vital contributor to the global scientific discourse.

🏅 Accolades and Recognition

Throughout his career, Professor Nazıroğlu has received numerous national and international honors, celebrating his scientific achievements and global engagement. These include the NATO Research Fellowship (Germany), the Alexander von Humboldt Fellowship (Germany), and the Young Investigative Scientist Award (USA). He has also been recognized by the Turkish Scientific and Technological Research Council (TÜBİTAK), the Howard Hughes Medical Institute (USA), and was the recipient of the prestigious Khwarizmi International Award (Iran). His visiting professorships at institutions in the UK, Qatar, and Japan further underscore his international reputation and collaboration.

🌍 Impact and Influence

Professor Nazıroğlu’s impact extends beyond academic publishing and conference organization. As a mentor, speaker, and panel member, he has shaped the careers of young neuroscientists and fostered a collaborative global network of researchers in calcium signaling and oxidative biology. His participation in expert advisory boards and scientific panels illustrates the depth of his influence on both research policy and biomedical innovation.

📘 Legacy of Knowledge

With over three decades dedicated to science and education, Professor Nazıroğlu has built a lasting legacy grounded in scientific rigor and visionary leadership. His conferences and educational programs, especially the International Brain Research School, have become cornerstone events for knowledge exchange in neuroscience. He has laid a strong foundation for future advancements in TRP channel research and neurophysiology.

🚀 Future Contributions and Vision

Looking forward, Professor Nazıroğlu continues to guide critical research on cellular responses to oxidative stress and ion channel modulation. His forward-thinking approach, combined with an inclusive scientific philosophy, ensures that he remains a leading voice in shaping the next era of biomedical research. With ongoing collaborative projects and mentorship of emerging scholars, his work is poised to influence both clinical and theoretical frontiers for years to come.

Publication

Title: Vitamin D Supplementation Modulates Blood and Tissue Zinc, Liver Glutathione and Blood Biochemical Parameters in Diabetic Rats on a Zinc-Deficient Diet
Authors: Kechrid, Z.; Hamdiken, M.; Nazıroğlu, M.; Flores-Arce, M.
Year: 2023

Title: Low molecular weight heparin treatment reduced apoptosis and oxidative cytotoxicity in the thrombocytes of patients with recurrent pregnancy loss and thrombophilia: Involvements of TRPM2 and TRPV1 channels
Authors: Dal, Y.; Nazıroğlu, M.; Özkaya, M.O.
Year: 2023

Title: NMDA Receptor Activation Stimulates Hypoxia-Induced TRPM2 Channel Activation, Mitochondrial Oxidative Stress, and Apoptosis in Neuronal Cell Line: Modular Role of Memantine
Authors: Kenan Yıldızhan; Mustafa Nazıroğlu
Year: 2023

Title: Honey bee venom melittin increases the oxidant activity of cisplatin and kills human glioblastoma cells by stimulating the TRPM2 channel
Authors: Kemal Ertilav; Mustafa Nazıroğlu
Year: 2023

Title: Silver nanoparticles potentiate antitumor and oxidant actions of cisplatin via the stimulation of TRPM2 channel in glioblastoma tumor cells
Authors: Yener Akyuva; Mustafa Nazıroğlu
Year: 2023

Title: A novel antagonist of TRPM2 and TRPV4 channels: Carvacrol
Author: Nazıroğlu, M.
Year: 2022

Title: Amantadine Attenuated Hypoxia-Induced Mitochondrial Oxidative Neurotoxicity, Apoptosis, and Inflammation via the Inhibition of TRPM2 and TRPV4 Channels
Authors: Öcal, Ö.; Coşar, A.; Nazıroğlu, M.
Year: 2022

Title: Eicosapentaenoic acid enhanced apoptotic and oxidant effects of cisplatin via activation of TRPM2 channel in brain tumor cells
Authors: Öcal, Ö.; Nazıroğlu, M.
Year: 2022

Title: Paclitaxel Promotes Oxidative Stress–Mediated Human Laryngeal Squamous Tumor Cell Death through the Stimulation of Calcium and Zinc Signaling Pathways: No Synergic Action of Melatonin
Authors: Kumbul, Y.Ç.; Nazıroğlu, M.
Year: 2022

Title: Protective role of selenium on MPP⁺ and homocysteine-induced TRPM2 channel activation in SH-SY5Y cells
Authors: Yıldızhan, K.; Nazıroğlu, M.
Year: 2022

🧾 Conclusion

Through an outstanding blend of academic excellence, innovative research, and global collaboration, Professor Nazıroğlu has carved a legacy as a leading figure in neuroscience and biophysics. His efforts in organizing international platforms and mentoring young scientists reflect a career committed to advancing knowledge and fostering global scientific networks. With continued contributions and visionary leadership, he remains a driving force in shaping the future of cellular neurophysiology and therapeutic discovery.

Hao Lai | Clinical Neuroscience | Best Researcher Award

Posted on 29/04/2025 by Neuroscientists

Prof. Dr. Hao Lai | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Hao Lai, Zhongshan Hospital, Fudan University, China.

Dr. Hao Lai is a distinguished cardiovascular surgeon and researcher, currently serving as Chief Physician at Zhongshan Hospital, Fudan University. With over 20 years of clinical expertise, he specializes in aortic and cardiovascular surgery. His academic achievements include a Ph.D. in Surgery from Fudan University and significant contributions to the study of epigenetic mechanisms in thoracic aortic dissection. As a principal investigator of nationally funded projects and co-author of influential publications, Dr. Lai combines scientific rigor with clinical innovation. He has also played a key role in medical education and device development through industry collaboration.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Hao Lai began his academic journey with a strong foundation in medical sciences, culminating in a Ph.D. in Surgery from the prestigious Fudan University. His early academic pursuits were marked by a deep interest in cardiovascular physiology and surgical intervention, which later matured into a specialized focus on aortic diseases. His time as a doctoral candidate not only equipped him with rigorous scientific training but also ignited his lifelong commitment to solving complex clinical problems through research.

🏥 Professional Endeavors

Currently serving as Chief Physician at Zhongshan Hospital, Fudan University, Dr. Hao Lai has accumulated over two decades of extensive clinical experience in cardiovascular and aortic surgery. His professional trajectory reflects a seamless integration of surgical excellence with academic leadership. At Zhongshan Hospital, a leading institution in China, he has spearheaded several clinical programs aimed at enhancing patient outcomes in cases of thoracic aortic dissection and other high-risk cardiovascular conditions.

🔬 Contributions and Research Focus

Dr. Lai’s research centers around the epigenetic mechanisms underlying thoracic aortic dissection, with a particular focus on histone modification and DNA methylation. He is the Principal Investigator of a major research project funded by the National Natural Science Foundation of China, which explores the role of H3K36me3 histone modification and DNMT3B-mediated gene body methylation in the pathogenesis of aortic dissection. His scientific efforts bridge molecular pathology with clinical implications, offering new perspectives on the diagnosis and treatment of life-threatening vascular disorders.

🏆 Accolades and Recognition

A respected voice in cardiovascular medicine, Dr. Hao Lai has co-authored numerous influential articles in high-impact journals such as Cardiovascular Research and Advanced Science. His h-index of 18, as listed on Scopus, reflects his consistent scholarly output and the wide academic acknowledgment of his work. In addition, his authorship of the textbook Practical Surgery (3rd Edition), published by People’s Medical Publishing House, stands as a testament to his educational contributions to the next generation of Chinese surgeons.

🧪 Impact and Innovation

Dr. Lai’s research has made a tangible impact on the understanding and treatment of aortic diseases. His investigation into the epigenetic regulation of vascular pathology has opened new avenues for targeted therapies. Moreover, his collaboration with MicroPort Endovascular MedTech demonstrates his commitment to translating research findings into real-world applications, particularly in the development and refinement of endovascular surgical devices.

🌍 Influence and Collaboration

Beyond his direct research and surgical contributions, Dr. Lai’s influence extends into collaborative domains, both nationally and internationally. His leadership in high-level research grants, clinical trials, and industrial partnerships positions him as a central figure in the evolving landscape of cardiovascular surgery. His collaborative spirit fosters innovation and promotes cross-disciplinary dialogue, essential in today’s complex medical research environment.

🔮 Legacy and Future Contributions

As Dr. Hao Lai continues his distinguished career, his legacy is being shaped not only by his surgical accomplishments but also by his contributions to medical science. His ongoing projects are likely to further clarify the molecular landscape of aortic diseases and inspire new therapeutic strategies. Looking ahead, Dr. Lai is poised to remain at the forefront of cardiovascular innovation, committed to improving patient care through a synthesis of research, education, and clinical practice.

Publication

Title: Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study
Authors: J. Cui, Y. Zhang, Y. Wang, Q. Ji, C. Wang
Year: 2025

Title: A novel open-vascular single-branched stent graft in total arch repair of type A aortic dissection one-year results of a prospective multicenter randomized controlled study
Authors: J. Gu, W. Zhang, L. Kang, H. Lai, C. Wang
Year: 2025

Title: Fibroblast Activation Protein Acts as a Biomarker for Monitoring ECM Remodeling During Aortic Aneurysm via 68Ga-FAPI-04 PET Imaging
Authors: C. Hu, H. Tan, Y. Zhang, X. Chen, L. Wang
Year: 2025

Title: Mitochondrial NAD+ deficiency in vascular smooth muscle impairs collagen III turnover to trigger thoracic and abdominal aortic aneurysm
Authors: J. Zhang, Y. Tang, S. Zhang, K. Zhu, W. Zhang
Year: 2025

Title: Correcting mitochondrial loss mitigates NOTCH1-related aortopathy in mice
Authors: Y. Tang, J. Zhang, Y. Fang, Y. Xu, W. Zhang
Year: 2025

Title: Exploration of 68Ga-FAPI-04 PET/MR in Chronic Type B Aortic Dissection
Authors: C. Hu, Y. Zhang, S. Qiu, H. Shi, L. Wang
Year: 2025

Title: Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: A randomized controlled trial
Authors: M. Luo, J. Luo, X. Xu, G. Tu, Z. Luo
Year: 2024

Title: Therapeutic results of three-dimensional aortic valve anatomic repair for regurgitant bicuspid aortic valve
Authors: J. Li, C. Wang, Z. Zuo, W. Ding, T. Hong
Year: 2024

Title: 68Ga-FAPI-04 Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Ascending Aortic Aneurysm
Authors: C. Hu, H. Tan, Y. Zhang, H. Lai, L. Wang
Year: 2024

Title: Sex-based outcomes after thoracic endovascular aortic repair: A systematic review and meta-analysis
Authors: Y. Zhang, Y. Zhang, Y. Wang, L. Wang, Q. Ji
Year: 2025

✅ Conclusion

Dr. Hao Lai’s career represents a powerful blend of surgical precision, scientific insight, and academic leadership. His work has advanced the understanding of aortic diseases at the molecular level while improving surgical outcomes for patients. As he continues to mentor, innovate, and lead research at the intersection of epigenetics and cardiovascular pathology, Dr. Lai’s contributions are set to leave a lasting legacy in both clinical practice and medical science.

CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Posted on 26/04/2025 by Neuroscientists

Prof. Dr. CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr. CARMINA MONTOLIU, UNIVERSIDAD DE VALENCIA/INCLIVA, Spain.

Carmina Montoliu Felix, a Valencia-born scientist and educator, is a distinguished Catedrática de Universidad at the Universidad de Valencia, specializing in Cellular Biology and Pathology. With a strong foundation in biomedical sciences and a dual role in both academia and clinical research through INCLIVA, she has become a key figure in translational medicine in Spain. Her work focuses on uncovering cellular mechanisms of disease, supported by national recognition such as her Group A classification by ISCIII. With extensive contributions indexed on platforms like ORCID and Scopus, she has gained international visibility and continues to influence the fields of pathology and biomedicine.

Profile

Orcid

🎓 Early Academic Pursuits

Carmina Montoliu Felix was born in Valencia, where she also pursued her academic career rooted in the life sciences. Her early interest in biology and medical sciences led her through a rigorous academic pathway that would eventually shape her into a leading figure in cellular pathology. With a profound dedication to understanding human disease at the cellular level, she cultivated a strong foundation in biology, which became the cornerstone of her future specialization in Cellular Biology and Pathology. These formative years instilled in her a passion for translational research, which continues to drive her work.

🏛️ Professional Endeavors

Currently serving as a Catedrática de Universidad at the Facultad de Medicina y Odontología of the Universidad de Valencia, Carmina Montoliu Felix holds a prestigious position within the Departamento de Patología, specifically in the Unidad de Biología. She achieved this distinguished academic rank on November 3, 2023, under BOE nº 274, a recognition of her academic excellence and contributions to higher education. Alongside her academic post, she is also an investigadora adscrita at the Fundación INCLIVA, playing a dual role in both teaching and active biomedical research. Her employment reflects the seamless integration between university instruction and clinical research aimed at improving patient outcomes.

🧬 Contributions and Research Focus

Carmina Montoliu Felix has been a pivotal contributor to the field of Cellular Biology, with specific expertise in Pathology (Área 661). Since February 29, 2012, she has been classified as a Group A Researcher within the Instituto de Salud Carlos III (ISCIII) framework. Her research activities are aligned with the Programa de Estabilización de Investigadores and the Sistema Nacional de Salud (I3SNS), focusing on intensifying biomedical research and fostering translational discoveries. Her scientific work is characterized by its interdisciplinary nature and commitment to uncovering the molecular basis of diseases, contributing significantly to both national and international health research landscapes.

🏅 Accolades and Recognition

Dr. Montoliu Felix’s academic excellence has been affirmed through numerous accolades, including the Group A classification by the Comisión Técnica de Evaluación de Recursos Humanos del ISCIII, one of the highest distinctions for biomedical researchers in Spain. Her appointment as a full professor is a testament to her leadership in medical education and scientific research. She is widely recognized among her peers for her scholarly impact, rigor, and commitment to nurturing future scientists and medical professionals.

🌍 Impact and Influence

Her work not only resonates within academic circles but also extends into clinical research through her active role at INCLIVA. By integrating research and practice, Carmina Montoliu Felix exemplifies how scientific inquiry can lead to tangible health benefits. Her influence spans collaborations with national healthcare systems and academic institutions, reinforcing her role as a key figure in the biomedical field. Through platforms such as ORCID and Scopus (ORCID ID: 0000-0002-4740-4788; Scopus ID: 6701923138), her contributions are accessible globally, further amplifying her scientific impact.

🔬 Legacy and Future Contributions

With a career marked by consistent advancement and dedication to discovery, Carmina Montoliu Felix is poised to continue shaping the future of cellular pathology and biomedical research in Spain and beyond. Her dual engagement in academia and clinical research ensures that her legacy will include both scientific breakthroughs and a generation of inspired students and researchers. Looking ahead, she is expected to further expand the integration of molecular biology into clinical diagnostics, ultimately improving patient care through science.

📚 A Life Committed to Science and Society

Beyond her technical expertise and professional roles, Carmina Montoliu Felix embodies the ideals of a scholar deeply committed to the betterment of society through science. Her residence and professional base in Valencia, her continuous academic contributions, and her service within public institutions paint the portrait of a researcher who bridges the lab and the community. Through her enduring efforts, she not only advances knowledge but also enhances the collective understanding of human health and disease.

Publication

Title: Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
Authors: Lyudmila Tikhonova; Eugene Maevsky; Carmina Montoliu; Elena Kosenko
Year: 2025

Title: Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence
Authors: Gubidat Alilova; Lyudmila Tikhonova; Carmina Montoliu; Elena Kosenko
Year: 2024

Title: Automatic Video-Oculography System for Detection of Minimal Hepatic Encephalopathy Using Machine Learning Tools
Authors: Alberto Calvo Córdoba; Cecilia Elisabet García Cena; Carmina Montoliu
Year: 2023

Title: Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Amparo Urios; MP Ballester; Teresa San-Miguel; Javier Megías Vericat; Elena Kosenko; Tosca J; Maria-Pilar Rios et al.
Year: 2023

Title: Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease
Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Carla Giménez-Garzó; Amparo Urios; MP Ballester; Lucia Durbán; Maria-Pilar Rios; Javier Megías Vericat; Teresa San-Miguel et al.
Year: 2023

Title: Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease
Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
Year: 2023

Title: Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy
Authors: Juan José Gallego; Alessandra Fiorillo; Franc Casanova-Ferrer; Amparo Urios; MP Ballester; Lucia Durbán; Javier Megías; Teresa Rubio; Andrea Cabrera-Pastor; Desamparados Escudero-García et al.
Year: 2022

Title: Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
Authors: Teresa San-Miguel; Javier Megías; Daniel Monleon; Lara Navarro Cerveró; Lisandra Muñoz; Carmina Montoliu; Marina Meri; Pedro Roldán; Miguel Cerdá-Nicolás; Concha López-Ginés
Year: 2022

Title: Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?
Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
Year: 2022

Title: A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease
Authors: Carla Giménez-Garzó; Alessandra Fiorillo; MP Ballester; Juan José Gallego Roig; Franc Casanova-Ferrer; Amparo Urios; Salvador Benlloch; Marti-Aguado D; Teresa San-Miguel; Tosca J et al.
Year: 2021

✅ Conclusion

Carmina Montoliu Felix’s career reflects a rare blend of scientific rigor, academic leadership, and social impact. Her journey from student to full professor showcases her dedication to advancing both knowledge and healthcare. As she continues to lead research at the intersection of cellular biology and clinical application, her legacy will not only be measured in published studies and prestigious titles, but also in the real-world health outcomes and inspired minds her work cultivates. Her future contributions promise to deepen our understanding of disease and strengthen the bridge between science and society.

Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Posted on 26/04/2025 by Neuroscientists

Prof. Dr. Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Dr. Gu Naibing is a distinguished Chief Physician in the Department of Neurology at Xi’an Central Hospital, specializing in neuroimmunology. He has made significant contributions to the understanding of neurological diseases, particularly those related to autoimmune and inflammatory conditions of the nervous system. As a Master’s degree supervisor and an active member of several professional committees, Dr. Gu has established himself as a leader in the fields of neurology and neuroimmunology. His research, clinical expertise, and involvement in medical organizations have earned him recognition and influence in the medical community. His work continues to have a lasting impact on both the treatment of neurological diseases and the education of future healthcare professionals.

Profile

Scopus

👨‍⚕️ Early Academic Pursuits

Dr. Gu Naibing embarked on his academic journey with a keen interest in neurology and medicine. After completing his medical degree, he pursued further studies in the specialized field of neurology, which led to the completion of his Master’s degree. Throughout his academic tenure, Dr. Gu consistently demonstrated a strong dedication to advancing his understanding of complex neurological conditions. His early academic endeavors set the foundation for a career focused on improving patient outcomes and advancing scientific knowledge in neuroimmunology.

💼 Professional Endeavors

Dr. Gu Naibing has established himself as a prominent figure in the field of neurology. As a Chief Physician in the Department of Neurology at Xi’an Central Hospital, he plays a vital role in diagnosing and treating a wide range of neurological disorders. Additionally, he serves as a Master’s degree supervisor, contributing to the training and development of the next generation of medical professionals. His professional network includes multiple roles in prestigious committees, such as the Neuroimmunology Professional Committee of the Shaanxi Provincial International Medical Exchange Promotion Association and the Neurology Branch of the Xi’an Medical Association.

🔬 Contributions and Research Focus

Dr. Gu’s research primarily focuses on neuroimmunology, the intersection of the immune system and neurological diseases. His work has advanced understanding in this field, particularly with regard to the mechanisms underlying autoimmune disorders affecting the nervous system. By contributing to a deeper understanding of brain diseases, Dr. Gu’s research has had significant implications for the development of more effective treatments for patients suffering from conditions such as multiple sclerosis, encephalitis, and other neuroinflammatory disorders. His focus on integrating immunological and neurological disciplines has been pivotal in pushing the boundaries of clinical research.

🏆 Accolades and Recognition

Throughout his career, Dr. Gu Naibing has earned several accolades and recognition for his outstanding contributions to the medical field. His involvement in various professional committees highlights his leadership and influence in the realm of neurology and neuroimmunology. As a standing committee member of the Neuroimmunology Group and the Neurology Professional Committee of the Shaanxi Health Care Association, Dr. Gu’s expertise and leadership are regularly sought after. His recognition extends beyond clinical practice, as he is frequently invited to contribute to national and international discussions on neurological care and research.

🌍 Impact and Influence

Dr. Gu Naibing’s influence extends beyond his clinical and research activities. Through his active involvement in professional organizations, he has had a profound impact on the development of neurology and neuroimmunology practices in China. His leadership in committees, particularly within the Shaanxi Medical Communication Association, has helped bridge gaps between medical professionals, facilitating the exchange of ideas and research findings. His dedication to fostering collaboration among medical communities has contributed to the enhancement of healthcare practices and the overall improvement of patient care.

🧠 Legacy and Future Contributions

As Dr. Gu Naibing continues his work, his legacy in the fields of neurology and neuroimmunology will undoubtedly inspire future generations of healthcare professionals. His commitment to advancing both clinical and research practices ensures that his contributions will have a lasting impact on the treatment of neurological diseases. Looking ahead, Dr. Gu is poised to continue making significant strides in neuroimmunology, with ongoing research and collaborations aimed at developing new therapeutic approaches. His future contributions promise to further shape the landscape of neurological healthcare, enhancing the lives of patients around the world.

🌟 Final Thoughts

Dr. Gu Naibing’s career has been defined by his passion for neurology, his commitment to advancing research, and his tireless efforts to improve patient outcomes. As a clinician, educator, and researcher, he has earned the respect and admiration of his peers, contributing significantly to the advancement of medical knowledge and patient care. With his continued dedication to the field, Dr. Gu’s legacy is sure to endure, influencing both the scientific community and the generations of healthcare professionals who follow in his footsteps.

Publication

Title: Effect of BMSCs overexpressing intelectin-1 on angiogenesis in rats with cerebral infarction
Authors: B. Zhu, K. Guo, L. Zha, L. Chang, N. Gu
Year: 2025

Title: Salivary duct carcinoma presenting with unilateral multiple cranial nerve lesions and concurrent intracranial metastasis: A case report
Authors: B. Zhu, Q. Zhang, K. Guo, Y. Yang, X. Jia
Year: 2025

Conclusion

Dr. Gu Naibing’s career is a testament to his dedication to advancing the field of neurology and neuroimmunology. His groundbreaking research, leadership in medical committees, and commitment to education have shaped the future of neurological care in China. With his continued focus on improving patient care and expanding scientific knowledge, Dr. Gu is poised to make lasting contributions that will positively impact both the medical field and the lives of countless patients. His legacy will inspire future generations of researchers and clinicians in the realm of neurology.

Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Posted on 22/04/2025 by Neuroscientists

Dr. Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Dr. Clotilde Guidetti, Harvard Medical School, Massachusetts General Hospital, United States.

Clotilde Guidetti is an accomplished early-career physician-scientist specializing in Child and Adolescent Neuropsychiatry. With a classical foundation and medical training from the University of Genoa, she excelled academically, earning multiple merit awards and graduating Summa Cum Laude. She completed her specialized residency at the Catholic University of Rome, further refining her clinical expertise. Clotilde’s research focus lies in neurodevelopmental disorders, behavioral interventions, and psychopharmacology in pediatric populations. She has already demonstrated promise as an independent researcher through competitive grant submissions and award-winning conference presentations. Based in Boston, she is actively shaping a career that bridges clinical care and scientific innovation.

Profile

Scopus

🎓 Early Academic Pursuits

Clotilde Guidetti began her academic journey with a deep-rooted passion for understanding the human mind and behavior. She earned her High School Diploma in Classical Studies from the prestigious State High School Andrea D’Oria, an early indication of her strong intellectual curiosity and dedication to learning. This foundation in classical education provided her with a broad humanistic perspective that continues to inform her clinical and research approach. She then pursued her Medical Degree at the University of Genoa, where she graduated Summa Cum Laude in 2020. Her academic record was consistently marked by distinction, earning multiple Academic Merit Awards for clinical excellence during her medical studies.

🧠 Professional Endeavors

Following her graduation, Dr. Guidetti further specialized in the field of Child and Adolescent Neuropsychiatry through a rigorous residency program at the Catholic University of Rome. Completed in November 2024, her residency was also distinguished with Summa Cum Laude honors, reflecting both her clinical acumen and compassionate engagement with young patients. Her professional training combined intensive clinical work with scholarly research, preparing her to address complex neurodevelopmental and psychiatric disorders in children and adolescents.

🔬 Contributions and Research Focus

Dr. Guidetti’s primary research interests lie at the intersection of neurodevelopment, behavioral disorders, and psychopharmacology in pediatric populations. Her clinical insights are deeply enriched by her scientific inquiries, particularly those focused on the early diagnosis and personalized treatment of neuropsychiatric conditions. She has already begun shaping her independent research path, as seen in her recent submission for the Brain & Behavior Research Foundation Young Investigator Grant in January 2025. Her project, currently under review, reflects her growing reputation as an emerging scholar in the domain of pediatric neuropsychiatry.

🏅 Accolades and Recognition

Throughout her academic and clinical journey, Clotilde Guidetti has been the recipient of multiple honors that highlight her outstanding abilities. These include three Academic Merit Awards from the University of Genoa and a prestigious Erasmus Socrates Fellowship in 2017–2018, which broadened her training in an international context. In 2022, she received the Attilio Sabato Award from the Società Italiana di Neuropsicofarmacologia (SINPF) for the best poster presentation—an achievement that not only celebrated her communication skills but also her innovative scientific thinking in neuropsychopharmacology.

🌍 Impact and Influence

Though early in her career, Dr. Guidetti has already begun to leave a meaningful mark on the field of child and adolescent mental health. Her dual focus on clinical excellence and academic inquiry ensures that her work resonates both within medical communities and in the lives of the families she serves. With a practice grounded in empathy and scientific rigor, she exemplifies the new generation of clinician-scientists committed to transforming mental health care for the most vulnerable populations.

🧬 Legacy and Future Contributions

As she looks to the future, Clotilde Guidetti aims to expand her contributions to academic psychiatry through collaborative research, cross-disciplinary studies, and the mentorship of emerging professionals in the field. Her continued involvement in national and international research networks promises to amplify her influence, paving the way for innovative treatments and holistic models of care in pediatric neuropsychiatry. Her vision is firmly centered on early intervention, neurodevelopmental resilience, and the integration of clinical practice with cutting-edge neuroscience.

📚 Academic Footprint

Dr. Guidetti currently resides and practices in Boston, Massachusetts, where she continues to build her clinical and research profile. Her dual base—rooted in Italy and expanding into the United States—places her at the nexus of transatlantic collaboration. With each project and presentation, she further refines her expertise and extends her academic footprint, fostering a dynamic career defined by global engagement, intellectual integrity, and unwavering commitment to child and adolescent mental health.

Publication

Title: Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis
Authors: Guidetti, Clotilde; Feeney, Anna; Hock, Rebecca S.; Fava, Maurizio; Papakostas, George I.
Year: 2024

📝 Conclusion

Dr. Guidetti embodies the ideal of a compassionate clinician and rigorous academic, poised to make significant contributions to the future of child and adolescent mental health. Her career so far reflects a seamless blend of scholarly excellence, clinical sensitivity, and a drive to push the boundaries of understanding in neuropsychiatry. As she continues to expand her research and collaborative efforts globally, her work promises to influence both scientific discourse and practical approaches in mental health care—building a legacy rooted in evidence, empathy, and innovation.